Aizen Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $13M

  • Investors
  • 3

Aizen Therapeutics General Information

Description

Operator of a drug discovery firm intended to cross and modulate biological barriers. The company utilizes spatial biology and artificial intelligence to provide new classes of medicines, enabling healthcare practitioners to improve medical treatments.

Contact Information

Website
www.aizentx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9276 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 9276 Scranton Road
  • Suite 500
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aizen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Nov-2024 $13M Completed Pre-Clinical Trials
To view Aizen Therapeutics’s complete valuation and funding history, request access »

Aizen Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Aizen Therapeutics’s complete cap table history, request access »

Aizen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aizen Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cercano Management PE/Buyout Minority
Madrona Venture Group Venture Capital Minority
Wilson Hill Ventures Venture Capital Minority
To view Aizen Therapeutics’s complete investors history, request access »

Aizen Therapeutics FAQs

  • When was Aizen Therapeutics founded?

    Aizen Therapeutics was founded in 2022.

  • Where is Aizen Therapeutics headquartered?

    Aizen Therapeutics is headquartered in San Diego, CA.

  • What is the size of Aizen Therapeutics?

    Aizen Therapeutics has 15 total employees.

  • What industry is Aizen Therapeutics in?

    Aizen Therapeutics’s primary industry is Drug Discovery.

  • Is Aizen Therapeutics a private or public company?

    Aizen Therapeutics is a Private company.

  • What is the current valuation of Aizen Therapeutics?

    The current valuation of Aizen Therapeutics is .

  • What is Aizen Therapeutics’s current revenue?

    The current revenue for Aizen Therapeutics is .

  • How much funding has Aizen Therapeutics raised over time?

    Aizen Therapeutics has raised $13M.

  • Who are Aizen Therapeutics’s investors?

    Cercano Management, Madrona Venture Group, and Wilson Hill Ventures have invested in Aizen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process